CN Patent

CN1233952A — 由鼻给药的去氨加压素

Assigned to Ferring AB · Expires 1999-11-03 · 27y expired

What this patent protects

本发明揭示了单剂有效和恒定血药浓度的经鼻给药的药物组合物,它包括体积为约5—75微升和约0.2—2.0mg/ml醋酸去氨加压素、摩尔相应量的去氨加压素或去氨加压素的药学上可接受的盐的水性溶液。该组合物能用来治疗诸如选自尿崩症、尿失禁、一般性遗尿和夜遗尿的泌尿疾病。

USPTO Abstract

本发明揭示了单剂有效和恒定血药浓度的经鼻给药的药物组合物,它包括体积为约5—75微升和约0.2—2.0mg/ml醋酸去氨加压素、摩尔相应量的去氨加压素或去氨加压素的药学上可接受的盐的水性溶液。该组合物能用来治疗诸如选自尿崩症、尿失禁、一般性遗尿和夜遗尿的泌尿疾病。

Drugs covered by this patent

desmopressin-acetate (DESMOPRESSIN ACETATE)

Patent Metadata

Patent number: CN1233952A
Jurisdiction: CN
Classification: —
Expires: 1999-11-03
Drug substance claim: No
Drug product claim: No
Assignee: Ferring AB
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.